Masuda Kyoko

マスダキョウコ | Masuda Kyoko

Affiliation and department：

Research field (1)： Immunology

Research keywords (3)：胸腺 , 発生 , T細胞分化

Research theme for competitive and other funds (6)：

2022 - 2025 抑制性レセプターに対する抗体分子によりNK細胞による拒絶反応の回避法の開発
2016 - 2019 Elucidation of molecular mechanism of the robustness between T and B cell lineage
2016 - 2018 Pathogenesis elucidation of seronegative spondyloarthritis using patient-derived iPSCs
2014 - 2016 Validation of safety and efficacy of regenerated antigen-specific T lymphocyte using iPS cell technology
2012 - 2014 Validation of the presence of myeloid-B progenitor stage towards to B cells on the differentiation pathway of hematopoiesis

Show all

Papers (56)：

Hiroshi Kawamoto, Kyoko Masuda. Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T cell therapies. International immunology. 2024
Hiroshi Kawamoto, Kyoko Masuda, Seiji Nagano. Development of Immune Cell Therapy Using T Cells Generated from Pluripotent Stem Cells. Advances in experimental medicine and biology. 2024. 1444. 207-217
Yosuke Nagahata, Kyoko Masuda, Yuji Nishimura, Tomokatsu Ikawa, Shinpei Kawaoka, Toshio Kitawaki, Yasuhito Nannya, Seishi Ogawa, Hiroshi Suga, Yutaka Satou, et al. Tracing the evolutionary history of blood cells to the unicellular ancestor of animals. Blood. 2022. 140. 24. 2611-2625
Koji Terada, Kenta Kondo, Hirohito Ishigaki, Ayaka Nagashima, Hiroki Satooka, Seiji Nagano, Kyoko Masuda, Teruhisa Kawamura, Takako Hirata, Kazumasa Ogasawara, et al. Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model. Molecular therapy oncolytics. 2022. 24. 77-86
Hiroshi Kawamoto, Kyoko Masuda, Seiji Nagano. Regeneration of antigen-specific T cells by using induced pluripotent stem cell (iPSC) technology. International Immunology. 2021

ｍore...

MISC (27)：

河本宏, 河本宏, 増田喬子, 永野誠治, 永野誠治. Cancer immunotherapy using T cells regenerated from iPS cells-Development of universal ”off-the-shelf” T cell medicine. 医学のあゆみ. 2022. 281. 5
Possible NK cell mediated immune responses against iPS-derived regenerated cells in allogenic transplantation. 2021. 276. 8. 809-817
Possible immune response against iPS-derived regenerated cells in allogenic transplantation. 2021. 20. 1. 16-32
河本宏, 増田喬子, 永野誠治, 永野誠治. Development of universal “off-the-shelf” T cells for cancer immunotherapy. 月刊腫瘍内科. 2021. 27. 5
Development of cancer immunotherapy using CTLs regenerated from iPS cells : To target solid tumor expressing WT1 antigen. 2020. 273. 5. 450-459

ｍore...

Professional career (1)：

Association Membership(s) (2)：

日本分子生物学会 , 日本免疫学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page